enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
-
Zelensky doubtful on Russian acceptance of Trump's 'energy ceasefire'
-
French supermarkets suffer refrigerator shutdown after 'unprecedented' cyberattack
-
Federal agents search home of Trump critic Ilhan Omar: government
-
Arsenal lose Hincapie and Zubimendi in freak double blow
-
Pakistan detains hundreds from ex-PM Khan's party as protests falter
-
Saudi says resilience tested, vows response after deadly airport attacks
-
Australia's Smith off field after being struck on helmet
-
Alcaraz exits Shanghai Masters in straight-sets loss
-
UK retains early access to test latest US AI models
-
Pope to enter hospital on Tuesday for lung operation
-
Top NATO commander warns Russia any attack would be 'futile'
-
Renshaw shines again before Australia declaration
-
Stolen Renoir paintings found behind wall in France: prosecutor
-
Atletico's Simeone encourages goalless Alvarez improvement
-
UNHCR sounds alarm on funding crisis
-
FXGLOBE Rebuilds Its Copy Trading and PAMM Business With B2BROKER's B2COPY
-
French supermarket chains say cyberattack forced refrigerator shutdown
-
Nepal rescuers search for missing after flash flood
-
Minister's resignation rocks German coalition
-
Oil rises as Trump comments roil energy markets
-
Hurricane Simon lashes Mexico's Pacific coast, threatens landfall
-
Premier League in limbo as Manchester City soar
-
France schools protest rumbles on as Macron urges 'respect'
-
Zelensky vows to respond as Moscow silent on 'energy ceasefire'
-
Americans Hall and Woodford win economics Nobel for stabilisation models
-
Thousands march in India's capital to demand election chief resign
-
MEXC Brings AI, TradFi and the Future of Trading to Life at TOKEN2049 Singapore
-
African players in Europe: Mbeumo ends goal drought as United draw
-
Italian rice farmer beats heat with biodiversity haven
-
France's high school students plan fresh protests
-
Stocks mixed as oil prices slip after Trump hails 'energy ceasefire'
-
NZ bank in free speech row over 'explicit' sheep memes
-
Opposition, journalists allege police abuses during India protests
-
China Open champ Zheng withdraws from Wuhan citing fatigue
-
DATA Network joins Sui and Walrus to scale the supply chain for AI training data
-
Brewers edge Dodgers 2-1 in National League Championship Series opener
-
Melbourne man linked to suspected flydubai hijacker condemns 'false accusations'
-
Pope to have surgery to remove lung nodule
-
North Korea fires 'several ballistic missiles' into Sea of Japan
-
Stocks rise as oil prices tumble after Trump hails 'energy ceasefire'
-
El Nino sets temperature record in key Pacific zone: EU monitor
-
Man City charges cloud hangs over Premier League season
-
Nature does not respect borders: UN biodiversity chief
-
Top NATO commander set to issue warning to Russia over any attack
-
World leaders urged to 'course correct' as UN nature goals fall short
-
Software, sprints, trolls: Singapore Grand Prix talking points
-
New York's notorious Rikers jail awaits elusive closure
-
Riyadh airport hit by fresh Houthi strike day after deadly attack
-
Unbeaten 49ers edge Seahawks while Vikings stay perfect
-
Ondas Announces Regna AI, Powered by Palantir, to Advance Sovereign AI
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
Watch the "What This Means" video here
IRVINE, CA / ACCESS Newswire / September 26, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor "What This Means" segment.
As part of the segment, Mr. Berman discussed the Company's recent news announcing it filed a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) received on August 19, 2025, in response to its Premarket Approval (PMA) application for the VenoValve®, a surgical replacement venous valve for treating severe deep chronic venous insufficiency (CVI).
The Virtual Investor "What This Means" segment featuring enVVeno Medical is now available here.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of severe deep Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The Company is currently performing the final testing necessary to seek IDE approval from the FDA to begin the U.S. pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
T.Perez--AT
